{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T17:56:37Z","timestamp":1770746197490,"version":"3.49.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T00:00:00Z","timestamp":1770681600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T00:00:00Z","timestamp":1770681600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Orthop Surg Traumatol"],"DOI":"10.1007\/s00590-025-04655-0","type":"journal-article","created":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T06:44:34Z","timestamp":1770705874000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Injectable synthetic bone graft substitute (GeneX) in the surgical management of benign bone tumours: further experience from a tertiary musculoskeletal oncology centre"],"prefix":"10.1007","volume":"36","author":[{"given":"Joseph J","family":"McAuley","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nima","family":"Razii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jack O","family":"Clark","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashish","family":"Mahendra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanjay","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,10]]},"reference":[{"key":"4655_CR1","first-page":"1","volume":"14","author":"CJ Chen","year":"2019","unstructured":"Chen CJ, Brien EW (2019) Early postoperative compilations of bone filling in curettage defects. J Orthop Surg Res 14:1\u20132","journal-title":"J Orthop Surg Res"},{"issue":"4","key":"4655_CR2","doi-asserted-by":"publisher","first-page":"102966","DOI":"10.1016\/j.otsr.2021.102966","volume":"108","author":"NF Gava","year":"2022","unstructured":"Gava NF, Engel EE (2022) Treatment alternatives and clinical outcomes of bone filling after benign tumour curettage. A systematic review. Orthop Traumatol Surg Res 108(4):102966","journal-title":"Orthop Traumatol Surg Res"},{"issue":"1SuppleA","key":"4655_CR3","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1302\/0301-620X.98B.36350","volume":"98","author":"Y Fillingham","year":"2016","unstructured":"Fillingham Y, Jacobs J (2016) Bone grafts and their substitutes. Bone Joint J 98(1SuppleA):6\u20139","journal-title":"Bone Joint J"},{"key":"4655_CR4","doi-asserted-by":"crossref","unstructured":"Lowery K, Chaturvedi A, Blomfield M, Sharma H (2018) Effectiveness of the management of bony articular collapse with bony defects in tibial plateau fractures with the use of GeneX: An absorbable calcium composite synthetic bone graft. J Limb Lengthen Recon 4:20\u201325.","DOI":"10.4103\/jllr.jllr_9_17"},{"issue":"5","key":"4655_CR5","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1016\/j.jos.2019.01.010","volume":"24","author":"WC Shin","year":"2019","unstructured":"Shin WC, Jang JH, Jeong JY, Suh KT, Moon NH (2019) Effect of a synthetic osteoconductive bone graft substitute with zeta potential control (geneX\u00ae ds) in the treatment of intertrochanteric fracture: A single center experience of 115 consecutive proximal femoral nail antirotations. J Orthop Sci 24(5):842\u2013849","journal-title":"J Orthop Sci"},{"key":"4655_CR6","doi-asserted-by":"crossref","unstructured":"Khan SA, Stephens A, Spalding T, Thompson P (2024) Use of Fast-Setting Bone Graft Substitute to Allow Single-Stage Revision Anterior Cruciate Ligament Reconstruction. Video J Sports Med 16;4(5):26350254241263973.","DOI":"10.1177\/26350254241263973"},{"issue":"4","key":"4655_CR7","doi-asserted-by":"publisher","first-page":"3697","DOI":"10.3390\/curroncol30040281","volume":"30","author":"N Razii","year":"2023","unstructured":"Razii N, Docherty LM, Halai M, Mahendra A, Gupta S (2023) Injectable synthetic beta-tricalcium phosphate\/calcium sulfate (GeneX) for the management of contained defects following curettage of benign bone tumours. Curr Oncol 30(4):3697\u20133707","journal-title":"Curr Oncol"},{"issue":"8","key":"4655_CR8","doi-asserted-by":"publisher","first-page":"e3","DOI":"10.1136\/jnnp.2010.232371","volume":"82","author":"S Saadoun","year":"2011","unstructured":"Saadoun S, MacDonald C, Bell BA, Papadopoulos MC (2011) Dangers of bone graft substitutes: lessons from using GeneX. J Neurol Neurosurg Psychiatry 82(8):e3","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"4655_CR9","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1007\/s11999-013-3305-z","volume":"472","author":"J Friesenbichler","year":"2014","unstructured":"Friesenbichler J, Maurer-Ertl W, Sadoghi P, Pirker-Fruehauf U, Bodo K, Leithner A (2014) Adverse reactions of artificial bone graft substitutes: lessons learned from using tricalcium phosphate geneX\u00ae. Clin Orthop Relat Res 472:976\u2013982","journal-title":"Clin Orthop Relat Res"},{"issue":"2","key":"4655_CR10","doi-asserted-by":"publisher","first-page":"135","DOI":"10.13004\/kjnt.2015.11.2.135","volume":"11","author":"JH Park","year":"2015","unstructured":"Park JH, Suh SJ, Lee YS, Lee JH, Ryu KY, Kang DG (2015) Lytic complications after skull reconstruction using GeneX\u00ae. Korean J Neurotrauma 11(2):135","journal-title":"Korean J Neurotrauma"},{"issue":"17","key":"4655_CR11","doi-asserted-by":"publisher","first-page":"4258","DOI":"10.3390\/cancers15174258","volume":"15","author":"MA Smolle","year":"2023","unstructured":"Smolle MA, Roessl V, Leithner A (2023) Effect of local adjuvants following curettage of benign and intermediate tumours of bone: a systematic review of the literature. Cancers 15(17):4258","journal-title":"Cancers"},{"key":"4655_CR12","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/BF00266874","volume":"8","author":"A Kreicbergs","year":"1985","unstructured":"Kreicbergs A, L\u00f6nnqvist PA, Nilsson B (1985) Curettage of benign lesions of bone: factors related to recurrence. Int Orthop 8:287\u2013294","journal-title":"Int Orthop"},{"issue":"1","key":"4655_CR13","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1080\/17453670902804505","volume":"80","author":"M Hirn","year":"2009","unstructured":"Hirn M, de Silva U, Sidharthan S, Grimer RJ, Abudu A, Tillman RM, Carter SR (2009) Bone defects following curettage do not necessarily need augmentation: A retrospective study of 146 patients. Acta Orthop 80(1):4\u20138","journal-title":"Acta Orthop"},{"issue":"1","key":"4655_CR14","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1186\/s13018-023-04215-4","volume":"18","author":"GG Krebbekx","year":"2023","unstructured":"Krebbekx GG, Fris FJ, Schaap GR, Bramer JA, Verspoor FG, Janssen SJ (2023) Fracture risk after intralesional curettage of atypical cartilaginous tumors. J Orthop Surg Res 18(1):851","journal-title":"J Orthop Surg Res"},{"issue":"1","key":"4655_CR15","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1080\/17453670710014815","volume":"79","author":"AH Kivioja","year":"2008","unstructured":"Kivioja AH, Blomqvist C, Hietaniemi K, Trovik C, Walloe A, Bauer HCF et al (2008) Cement is recommended in intralesional surgery of giant cell tumors: a Scandinavian sarcoma group study of 294 patients followed for a median time of 5 years. Acta Orthop 79(1):86\u201393","journal-title":"Acta Orthop"},{"issue":"1","key":"4655_CR16","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1186\/s12891-022-05447-x","volume":"23","author":"S Tsukamoto","year":"2022","unstructured":"Tsukamoto S, Mavrogenis AF, Akahane M, Honoki K, Kido A, Tanaka Y, Donati DM, Errani C (2022) Risk factors of fracture following curettage for bone giant cell tumors of the extremities. BMC Musculoskelet Disord 23(1):477","journal-title":"BMC Musculoskelet Disord"},{"issue":"6","key":"4655_CR17","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1016\/0363-5023(88)90269-9","volume":"13","author":"RD Bauer","year":"1988","unstructured":"Bauer RD, Lewis MM, Posner MA (1988) Treatment of enchondromas of the hand with allograft bone. J Hand Surg 13(6):908\u2013916","journal-title":"J Hand Surg"},{"issue":"11","key":"4655_CR18","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.2106\/00004623-199511000-00017","volume":"77","author":"WW Tomford","year":"1995","unstructured":"Tomford WW (1995) Transmission of disease through transplantation of musculoskeletal allografts. JBJS 77(11):1742\u20131754","journal-title":"JBJS"},{"key":"4655_CR19","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1097\/00003086-199101000-00005","volume":"262","author":"GL GLANCY","year":"1991","unstructured":"GLANCY GL, BRUGIONI DJ (1991) Autograft versus allograft for benign lesions in children. Clin Orthop Relat Res 262:28\u201333","journal-title":"Clin Orthop Relat Res"},{"issue":"1","key":"4655_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13018-025-05857-2","volume":"20","author":"S Mohammadi","year":"2025","unstructured":"Mohammadi S, Phull SS, Bal BS, Towler MR (2025) Bone void filler materials for augmentation in comminuted fractures: a comprehensive review. J Orthop Surg Res 20(1):1\u20132","journal-title":"J Orthop Surg Res"},{"issue":"7","key":"4655_CR21","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1002\/jbm.b.32758","volume":"100","author":"HL Yang","year":"2012","unstructured":"Yang HL, Zhu XS, Chen L, Chen CM, Mangham DC, Coulton LA, Aiken SS (2012) Bone healing response to a synthetic calcium sulfate\/\u03b2-tricalcium phosphate graft material in a sheep vertebral body defect model. J Biomed Mater Res Part B Appl Biomater 100(7):1911\u20131921","journal-title":"J Biomed Mater Res Part B Appl Biomater"},{"issue":"8","key":"4655_CR22","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.2106\/00004623-199173080-00002","volume":"73","author":"WF Enneking","year":"1991","unstructured":"Enneking WF, Mindell ER (1991) Observations on massive retrieved human allografts. JBJS 73(8):1123\u20131142","journal-title":"JBJS"},{"issue":"2","key":"4655_CR23","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1148\/rg.262055039","volume":"26","author":"FD Beaman","year":"2006","unstructured":"Beaman FD, Bancroft LW, Peterson JJ, Kransdorf MJ, Menke DM, DeOrio JK (2006) Imaging characteristics of bone graft materials. Radiographics 26(2):373\u2013388","journal-title":"Radiographics"},{"issue":"2","key":"4655_CR24","doi-asserted-by":"publisher","first-page":"233","DOI":"10.4055\/cios.2019.11.2.233","volume":"11","author":"H Chung","year":"2019","unstructured":"Chung H, Kim S, Chung SH (2019) Clinical outcome of beta-tricalcium phosphate use for bone defects after operative treatment of benign tumors. Clin Orthop Surg 11(2):233\u2013236","journal-title":"Clin Orthop Surg"},{"key":"4655_CR25","doi-asserted-by":"publisher","first-page":"649","DOI":"10.4103\/0019-5413.168767","volume":"49","author":"AK Gupta","year":"2015","unstructured":"Gupta AK, Kumar P, Keshav K, Singh A (2015) Hydroxyapatite crystals as a bone graft substitute in benign lytic lesions of bone. Indian J Orthop 49:649\u2013655","journal-title":"Indian J Orthop"}],"container-title":["European Journal of Orthopaedic Surgery & Traumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00590-025-04655-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00590-025-04655-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00590-025-04655-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T06:44:35Z","timestamp":1770705875000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00590-025-04655-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,10]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4655"],"URL":"https:\/\/doi.org\/10.1007\/s00590-025-04655-0","relation":{},"ISSN":["1432-1068"],"issn-type":[{"value":"1432-1068","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,10]]},"assertion":[{"value":"3 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests. No funds, grants, or other support was received from any organization for the submitted work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"101"}}